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The vascular switchboard. The endothelium is exposed to a constant cacophony of 
simultaneous instructions from hormones, neurotransmitters, pericytes, smooth muscle cells, 
various blood cells, viral or bacterial infection and proinflammatory cytokines. It is often 
assumed that the endothelium maximizes the ability of tissues to respond to instructions through 
coordinated responses in a homogeneous population of cells. We show that the endothelium 
segregates chemical environment into separate, complementary streams of information that are 
processed in parallel, providing separate lines of information about the chemical environment 
like a vast switchboard.  Different, simultaneously arriving, inputs are passed among cells and 
computations carried out so that a new signal output is generated that is a composite of the 
inputs. The endothelium detects specific signals in a complex chemical environment by using 
cells that are not concerned with all possible available information but with only with a small 
specific part of the overall material and cells collaborate with neighbors in the distribution of 
information.  
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Abstract 
Blood flow, blood clotting, angiogenesis, vascular permeability and vascular remodeling are 
each controlled by a large number of variable, noisy and interacting chemical inputs to the 
endothelium. The endothelium processes the entire chemical composition to which the 
cardiovascular system is exposed, carrying out sophisticated computations to determine 
physiological output.  A major challenge faced by the endothelium is the requirement to process 
an enormous quantity of information held in the overall chemical environment to which the 
vascular system is exposed. We analyzed hundreds of endothelial cells and show that the 
endothelium segregates the chemical environment into small components of complementary 
information streams which are processed in parallel. Chemical stimuli arriving at the 
endothelium are mapped to different clusters of cells which each generate unique signal patterns. 
When there is more than one stimulus, cells communicate and combine inputs across information 
streams to generate new distinct signals. Our results establish the endothelium is a structured, 
collaborative, sensory network which simplifies the complex environment using separate cell 
clusters concerned with small distinct aspects of the overall information. These clusters 
interactively compute signals from the diverse but interrelated chemical inputs. These features 
permit the endothelium to selectively process separate signals and perform multiple 
computations in an environment that is noisy and variable. 
  
4 
 
Introduction 
The endothelium is a continuous network of ten trillion cells (1) that controls virtually all 
cardiovascular behavior. The endothelium is the sensory interface for an enormous quantity of 
information held in the chemical environment to which the vascular system is exposed and which 
provides cues on physiological status. Numerous signals are provided by blood composition, 
hormones, neurotransmitters, endothelial cells, pericytes, smooth muscle cells, various blood 
cells, viral or bacterial infection and proinflammatory cytokines that each provide instructions to 
the vascular system. Many (minimally tens) of these extracellular signals may arrive 
simultaneously, often fluctuating around basal concentration values creating multiple, small, 
difficult to resolve extracellular signals (2-5).  The endothelium processes the information held in 
the identity of the chemical activator and in the range of concentrations over which each 
fluctuates. The endothelium must manage multiple extracellular signals simultaneously requiring 
selective detection and processing of separate information. 
Although heterogeneity is appreciated to exist (6-9), the endothelium is usually treated as a 
homogeneous population of cells that responds uniformly to each activator. Indeed, it has often 
been assumed that biological systems maximize tissues’ ability to respond to perturbations 
through coordinated responses in homogeneous population of cells (10). The classical view of 
endothelial function is that information arriving via each cell is interpreted and conveyed to 
neighboring cells (e.g. other endothelial cells or smooth muscle), much like a cable, without 
changing the information content (11, 12). Given this proposed arrangement, precisely how the 
endothelium transduces multiple independent extracellular signals arriving simultaneously, to 
particular cell activities is not clear.   
Chemical stimuli that activate endothelial cells are often transduced to changes in cytosolic Ca2+ 
concentration (13-19) (but see 20). Ca2+ links extracellular stimuli to physiological response by 
regulating the synthesis and release of various vasoactive agents such as nitric oxide, 
prostacyclin, peptides and thromboxane (reviewed 21). Through these Ca2+-dependent mediators 
the endothelium controls vascular tone, nutrient exchange, blood cell recruitment, blood 
clotting and the formation of new blood vessels (reviewed 21). Cardiovascular function 
requires careful translation of the physiological information provided by extracellular activators, 
via changes in intracellular Ca2+, to regulate both single cell activity and the physiological 
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behavior of the entire endothelium. Translation occurs when the activity of intracellular 
processes alter in response to the Ca2+ signal. Specific targeting of particular intracellular 
processes by extracellular signals is believed to rely mainly on differentiation based on 
amplitude or temporal or spatial features of the Ca2+ signal within each cell (22-25). However, 
despite the diversity of signals, various activators evoke Ca2+ increases that often appear similar 
in their localized increases, uniform global rises or propagating waves that occur through all or 
part of a cell (26-29). How these Ca2+ signals selectively evoke a multitude of distinct 
physiological responses is not yet fully understood.  
When several chemical mediators are present simultaneously, the Ca2+ signal must integrate 
information from each source while still producing distinct signals to control multiple activities 
thus presenting an additional complex sensory problem. An appreciation of how Ca2+ selectively 
couples different sensory inputs in a complex chemical environment to various physiological 
functions is therefore central to an understanding of endothelial functioning. 
To control cardiovascular function the endothelium extracts information from a noisy and 
variable environment by performing multiple simultaneous determinations of chemical signals 
via changes in Ca2+ concentration to determine physiological status. Key to an understanding of 
this crucial aspect of the cardiovascular function are the mechanisms by which endothelial cells 
integrate information from the local chemical environment. To address this issue we recorded the 
concurrent activity from hundreds of endothelial cells in intact blood vessels and examined the 
responses to extracellular activators of muscarinic and purinergic receptors. The response to 
muscarinic receptor activation is thought to underlie the response hypothermia (30) and to shear-
stress activation (31). Purinergic stimulation may occur by ATP released from activated platelets 
(32, 33) to evoke vasodilation (34) and either an increase (35) or decrease (36) in endothelial 
permeability.  
Our results show the endothelium is organized into spatially-structured clusters of endothelial 
cells. The clusters focus on particular stimuli and separately process various elements of the 
chemical environment in parallel. Cells share information with neighbors. When more than one 
agonist is present, cells perform computations on inputs to generate new signals that are distinct 
from each of the individual contributions. The endothelium thus appears to act as a network of 
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structured, collaborating sensors that act in parallel to interpret the multiple signals that report 
physiological status.   
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Results 
The endothelium is a distributed sensory system that can detect a large number of chemical 
inputs (21, 37). However, it is not known if the distribution of sensory cells is uniform, random 
or clustered. As a first step in determining the distribution of sensory cells and how the 
endothelium responds to extracellular activators, agonist-induced Ca2+ signaling was studied in 
large numbers (~200) of endothelial cells in intact arteries.  
The muscarinic agonist carbachol (CCh; 100 nM) evoked an increase in Ca2+ concentration in 
several cells in the endothelium (Fig 2A; supplementary fig S1). The cells that activated 
appeared to form clusters in certain areas of the endothelium (Movie S1). Each active cell’s 
response consisted of Ca2+ waves that propagated across all or part of the cell (Movie S1).  Some 
cells were inactive or barely active and others highly active with repeating Ca2+ waves and 
oscillations (Fig 2A-F). The amplitude and duration of the responses also varied across cells 
(Fig 2C,D). The differences in amplitudes, duration and oscillation frequency from individual 
cells gave rise to a wide range of responses (Fig 2A,C,D). There also was considerable 
heterogeneity in the response to other types of activator including the flow-induced responses in 
the endothelium (supplementary fig S2). Despite the wide variation in amplitudes, durations and 
oscillations, when the response to CCh was averaged across all cells or the entire field of view, a 
monophasic rise in Ca2+ occurred (supplementary fig S1F).  
CCh-evoked changes in endothelial Ca2+ were required for relaxation of the arteries. When Ca2+ 
changes in the endothelium were buffered using the chelator BATPA (30 µM perfused into the 
artery lumen for 30 min), the relaxation evoked by a maximal concentration of carbachol (100 
µM) was inhibited (supplementary Fig S3).  
Concentration-dependence of cholinergic signaling 
Previous studies have shown the averaged or ensemble endothelial Ca2+ response to various 
stimuli increased in a concentration dependent manner (16, 38). However, it was not clear if 
these increases in response arose from an increase in the Ca2+ response in each single cell or an 
increase in the number of cells being activated (each responding with a maximum response); 
single cell concentration-response relationships are rarely carried out. Figure 2A shows that the 
number of cells responding with Ca2+ elevations, increased with CCh concentration. The cells 
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that activated to each concentration appeared to be positioned in clusters in various areas of the 
endothelium. The range (EC10-EC90) of CCh concentrations over which cells responded was 123 
nM – 1.2µM (95% confidence intervals: 76 – 199 nM for EC10; 740nM – 2.1 µM for EC90; Fig 
4D). This data indicates at least part of the concentration dependence of the response to 
muscarinic activation arises from increased recruitment of endothelial cells.  
In addition to the increased recruitment of cells, the amplitude of the Ca2+ response in each cell 
also increased in a concentration-dependent manner (Fig 4C,E). The half-maximal concentration 
of CCh for endothelial cell activity was 630 nM (95% confidence interval: 399 nM – 996 µM; 
supplementary Fig S4). The range (EC10-EC90) over which the magnitude of the Ca2+ response, 
of responding cells, increased was 50 nM – 8 µM (95% confidence intervals: 17 nM – 142 nM 
for EC10; 2.9 µM – 22.1 µM for EC90; supplementary Fig S4). Thus the concentration-dependent 
response was a combination of increasing recruitment of cells and increasing amplitude of 
response within cells (supplementary Fig S4).  
There were differences in the sensitivities of concentration-responses in amplitude and number 
of cells activated (supplementary fig S4). All cells could be activated before a maximal response 
was achieved as expected from a population of cells with various sensitivities (supplementary fig 
S4). A composite measure (supplementary fig S4) of the percentage cells activated multiplied by 
the average amplitude of the initial Ca2+ rise in responding cells, at each concentration shows the 
half-maximal concentration of CCh for total endothelial activation was 1.1 µM (95% confidence 
interval: 743 nM – 1.5 µM). The range (EC10-EC90) of concentration of CCh over which cells 
responded was 164 nM – 6.8 µM (95% confidence intervals: 76 nM – 354 nM for EC10; 3.2 µM 
– 14.8 µM for EC90). The concentration response relationship for total endothelial response 
(supplementary fig S4) was significantly right-shifted compared to the relationship describing 
percentage cell activation supplementary fig S4 versus Fig 4D; P<0.05). Thus, the concentration-
dependence of the response of individual cells extends the overall sensitivity of the endothelium. 
The Ca2+ increase evoked by CCh was generated via muscarinic receptors as confirmed by the 
complete block of the response by the M3 receptor antagonist 4-DAMP (100 nM; Fig 3). The 
experiment shown in Fig 3A-D begins with repeat activations with CCh (10 min between 
activation) to show reproducible responses. The M3 receptor antagonist (4-DAMP 100 nM) was 
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then applied and blocked the subsequent response to CCh. After block of the CCh response by 
the antagonist, ATP (100 µM) was applied to confirm viability of the endothelium (Fig 3A-D) 
Concentration-dependence of purinergic signaling 
In the next series of experiments, the response to the purinergic agonist ATP was examined (Fig 
4A). Ca2+ responses, averaged across all endothelial cells within the field-of-view, showed a 
concentration-dependent increase in magnitude of response (Fig 4B). The increasing response to 
ATP was, like CCh, derived from an increased number of cells activated and an increased 
amplitude of response in each cell (Fig 4A-E). The cells that activated to each concentration 
appeared to be positioned in clusters in various areas of the endothelium (Fig 4A).  
The half-maximal concentration of ATP for cell activation was 3.17 µM (95% confidence 
interval: 2.19 µM – 4.58 µM; Fig 4D). The range (EC10-EC90) of concentration of ATP over 
which cells responded was 438 nM – 22.9 µM (95% confidence intervals: 196 nM - 979 nM for 
EC10; 10.2 µM – 51.2 µM for EC90; supplementary fig S5). 
When the magnitude of the peak response was considered, the half-maximal concentration of 
ATP was 20.5 µM (95% confidence interval: 12.2 µM to 34.3 µM; supplementary fig S5). The 
range (EC10-EC90) for the magnitude of the Ca2+ response was 1.9 µM to 224 µM (95% 
confidence intervals: 590 nM - 5.9 µM for EC10; 71.2 µM – 700 µM for EC90). 
When a composite measure of the percentage cells activated, multiplied by the average 
amplitude of the initial Ca2+ rise, is assessed (supplementary fig S5), the half-maximal 
concentration of ATP for total endothelial activation was 21.4 µM (95% confidence interval: 
13.9 µM – 33.0 µM). The range (EC10-EC90) of concentration of ATP over which cells 
responded was 2.6 µM – 174 µM (95% confidence intervals: 1.0 µM – 6.7 µM for EC10; 68.1 – 
488 nM for EC90; supplementary fig S5). The concentration response relationship for the total 
endothelial response was, like CCh, significantly right-shifted compared to the relationship 
describing percentage cell activation (P<0.05). Thus, as with muscarinic activation, whilst there 
is only a narrow range of concentrations over which the endothelium as a whole responds to 
ATP, the concentration-dependence of the response of individual cells extends the overall 
sensitivity of the endothelium.  
10 
 
Activation of purinergic receptors by ATP respectively evoked relaxation of intact arteries. The 
relaxation evoked by ATP (100 µM), like that of CCh, required Ca2+ changes in the endothelium. 
When Ca2+ changes were buffered in the endothelium using the chelator BATPA (30 µM 
perfused into the artery lumen for 30 min), the relaxation evoked by a maximal concentration of 
ATP was blocked (supplementary Fig S3). 
The response to ATP was mediated by purinergic P2Y2 receptors. Two observations support this 
conclusion. First, the Ca2+ rise to ATP persisted in a Ca2+-free bath solution (Fig 5). In response 
to the ATP (EC25) the response was unaltered when extracellular Ca2+ was removed (Fig 5A-C). 
At a maximal ATP concentration (100 µM) the initial response was unaffected in a Ca2+-free 
bath. However, the later (45 s) sustained response to ATP was reduced suggesting that Ca2+ 
influx was required for this part of the ATP evoked Ca2+ rise (Fig 5F-H). Ca2+ influx in the later 
sustained responses appears to arise from store-operated Ca2+ entry rather than P2X receptor 
activation (see below).  
The second line of support for P2Y2 receptor involvement is that the responses to a maximal 
concentration (100 µM) of ATP (both initial and sustained) were largely blocked by the P2Y2 
receptor blocker ARC118925 (1 µM; 0.61±0.13 versus 0.13±0.06; Fig 6A). The small residual 
component for the response to ATP, after ARC118925, was blocked by the P2Y1 receptor 
antagonist (MRS2179, 10 µM; Fig 6A). The P2Y1 receptor antagonist MRS2179 had only a 
small inhibitory effect on the response to ATP (10 µM; 66% of controls 0.61±0.13 versus 
0.4019±0.09) (Fig 6). 
The almost complete block of the response to ATP by the P2Y2 antagonist suggests that the 
sustained part of the response involved store-operated Ca2+ entry rather than P2X receptor 
activation. 
Distribution of Sensitivities among cells to puringeric and muscarinic activation 
We next addressed the distribution of cells that were most sensitive to CCh and ATP. The 
concentration at which 25% and 75% of the cells responded to each agonist (EC25 and EC75) 
were obtained from the concentration response curves (Fig 2D & Fig 4D) and used to determine 
which cells were activated by low and high concentration of each agonist. The experiments 
examining each agonist were carried out on precisely the same preparation and field of 
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endothelial cells and show each agonist activates different spatially-distinct cells. In examining 
the different populations of cells activeated by each agonist, we restricted our analysis to the first 
4 seconds of activation to minimize Ca2+ waves moving from an activated cell (39). 
Fig 7A shows the cells activated by the EC25 and EC75 of CCh and ATP in a single endothelial 
preparation.  A low concentration of CCh (EC25) produced an initial response in a small 
percentage of endothelial cells (Fig 7Ai; n=5). Additional cells are subsequently recruited either 
by the agonist or by the Ca2+ increase in the initial responding cells propagating to neighboring 
cells (Fig 7Aii). The EC75 concentration of CCh also evoked a response in those cells that 
responded to the EC25 of CCh (Fig 7Ai first responding and 7Aii full response). However, more 
initial responders were activated by higher concentrations of the agonist (Fig 7Ai) and further 
cells were subsequently recruited. The EC25 and EC75 of ATP also produced a similar 
concentration-dependent activation of cells (Fig 7Ai & 7Aii). Cells that activated to the same 
agonist appeared to form clusters and the clusters activated by CCh were spatially-distinct from 
those cells activated by ATP (Fig 7A&B; Movie S2).   
The cells activated by each agonist were highly reproducible and the same pattern of cell activity 
for each agonist occurred when the sequence of activation of activation was reversed 
(supplementary fig S6). 
To provide a robust statistical description of cell spatial and neighbor relationships, we used a 
Voronoi tessellation analysis (Fig 7) (described in Methods).  Analysis of the Voronoi plots 
provide a quantitative method to determine the number of neighbors of each cell, and the number 
of co-activating neighboring cells i.e. a method to determine the extent of clustering. The 
analysis was restricted to the first 4s of activation, a time long enough to identify the first 
responding cells and short enough to minimize activation of cell due to signal propagation (39). 
This approach was taken in preference to the use of Gap junction blockers as we previously 
found carbenoxalone, glycyrrhetinic acid and GAP-27 each suppressed Ca2+ signals in the 
endothelium independently of effects on Gap junctions (8). The present results show that each 
cell has on average 6 neighbors, CCh-sensitive cells tended to be close to other CCh sensitive 
cells and ATP-sensitive cells tended to be close to other ATP sensitive cells (Fig 7B). 
Using Voronoi edge tessellation to define neighbors we determined the number of co-activating 
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neighbors responding to a given stimulus (Fig 7C,D).  Thus for every activating cell, the number 
of neighbors cells that also activate to the same stimulus was determined. From this data a null 
hypothesis was generated to suggest that there is no spatial correlation in the responses, i.e. that a 
cell is no more likely to activate if its neighbor activates.  The expected number of co-activating 
cells under the null hypothesis was calculated as the (mean number of neighbors; 6) * (activating 
fraction) for each agonist.  As this hypothesis can be arrived at by assigning the response/no 
response behavior to cells in a spatially random way, we call this the ‘random model’. 
The number of neighboring endothelial cells activated by equivalent (EC25 & EC75) 
concentrations of CCh and ATP (Fig 7C,D red dots) was significantly greater than predicted by 
the random model distribution of activated cells (Fig 7C,D blue dots), suggesting that cells that 
respond to each agonist tend to be neighbors and that cells are arranged in sensing clusters. The 
difference between the random model and observed response was greater in the first 4s of 
activation (Fig 7C) than the full duration data set (Fig 7D) presumably because cell-cell 
propagation increased the number of cells activated after this period and extended signals beyond 
the clusters.  
We next analyzed the extent of overlap in clusters that were activated by each agonist. In this 
analysis the cells that respond to one agonist were first identified. Then the percentage of 
precisely the same cells that respond to the second agonist was determined (note that the EC25 
and EC75 concentrations were derived from the concentration response data over the full duration 
of the response; Fig 4D & 7D). Summarized data (n=5) plotting the overlap in the cells activated 
by CCh and ATP during the first 4 seconds (first responding). The left side of the plot (Fig 7E; 
red) shows the total number of cells that have been activated as a percentage of the entire 
population of cells in the field by the condition in the red bar.  The right side of each plot (Fig 
7E) shows the percentage of the precisely the same cells identified on the left plot that are 
activated by each of the conditions shown on the x-axis. From this analysis it is clear that only a 
small percentage of cells that respond to CCh (EC25) also respond to ATP (EC25), and likewise 
that a small percentage of cells that respond to ATP (EC25) also respond to CCh (EC25).   
Confirmation that cell activation tended to occur in clusters is shown in the summarized data in 
Fig 7F showing responses to CCh and ATP in the same population.  Cluster sizes were measured 
by identifying interconnected cells from the Voronoi neighbor analysis. The number of cells in a 
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cluster (in the first 4s of activation) increased substantially with agonist concentration for CCh 
but the increase was much shallower for ATP (Fig 7F). This result suggests the extent of 
subsequent recruitment of cells after the first 4 s was substantially greater for ATP than CCh.  
The question arises as to why some cells respond more to one agonist than another. At least part 
of the explanation appears to be the distribution of M3 and P2Y2 receptors. Fluorescence 
labelling of M3 and P2Y2 receptors shows the distribution is highly heterogeneous (Fig 8). Some 
cells show increased M3 receptor labelling while other cells more P2Y2 receptor labelling (Fig 
8). Indeed, the cells that expressed M3 receptors were spatially distinct from the cells that 
expressed P2Y2 receptors with no significant overlap (P<0.05, n=5; Fig 8C,D). In these 
experiments cell boundaries were identified using PECAM-1 fluorescence. From the cell 
boundaries ROI’s were extracted to identify individual endothelial cells.  
The specificity of the P2Y2 antibody used in these experiments (Fig 8) was confirmed using 
wild-type 1321N1 cells and 1321N1 cells stably expressing recombinant human hP2Y2 
receptors (1321N1-hP2Y2)(40) (supplementary Fig S7). 1321N1 cells are a human astrocytoma 
cell line that do not endogenously express any of the eight P2Y receptor subtypes or respond to 
the naturally-occurring nucleotide agonist (41) and were used as a negative control 
(supplementary fig S7). The P2Y2 antibody labelled 1321N1-hP2Y2 but not wild-type 1321N1 
cells. The fluorescent ligand used to label M3 receptors was completely blocked by the M3 
receptor antagonist 4-DAMP (Fig 8). 
Heterogeneity in responses is not restricted to Ca2+. In another series of experiments the spatial 
heterogeneity in nitric oxide production was examined using the fluorophore DAR-4M (29). The 
production of nitric oxide largely occurred in separate cells in response to an EC50 concentration 
(for Ca2+) of CCh or ATP in the same preparation (supplementary fig S8). In this series of 
experiments, cells that generate nitric oxide to one agonist were first identified.  Then the 
percentage of precisely the same cells that respond to one agonist was determined for the second 
agonist. Summarized data (n=3) is plotted showing the overlap in the cells activated by CCh and 
ATP (supplementary fig S8B-C).  In supplementary fig S8B-C, the red bar shows the total 
number of cells that have been activated as a percentage of the entire population of cells in the 
field.  The right side of each plot (blue bars) shows the percentage of the precisely the same cells 
that are activated by the agonists shown on the x-axis. There is a significant difference in the 
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cells that respond to each agonist i.e. there is minimal overlap in the percentage of cells that 
respond to CCh with nitric oxide production with those that respond also to ATP.  
Together these results suggest clusters of cells have a higher sensitivity to muscarinic agonist 
while other, different clusters of cells have a high affinity for purinergic agonists. Thus the 
endothelium uses an agonist specific sensing systems for each agonist. 
Characteristics of Ca2+ signals 
The spatiotemporal features of the Ca2+ signals in response to low but equivalent concentrations 
(EC25) of CCh and ATP, evoked in the same preparation, differed substantially (Fig 9A-D). In 
single endothelial cells, CCh (EC25) evoked repetitive Ca2+ oscillations on an elevated baseline 
value (Fig 9B,C). The mean response from the activated cells (Fig 9B, green line) showed a 
slow, steady increase in Ca2+ which remained elevated throughout the treatment (Fig 9B). In 
contrast, a low concentration of ATP (EC25) evoked a rapid rise in Ca2+ followed by a decline 
back to resting values (Fig 9B). Several cells showed repetitive oscillations (Fig 9B). The mean 
response to the EC25 of ATP (Fig 9B, red line) was a sharp increase in Ca2+ that subsequently 
declined to baseline levels (Fig 9B). When CCh and ATP (each at their EC25) were applied 
together, the cells that responded to the combined treatment were the same cells that responded 
to the separate application of each agonist (Fig 9A).  
Interestingly, when both agonists (CCh and ATP) were present, the Ca2+ responses appeared to 
be a composite of the amplitudes and temporal features of the signals derived from each agonist 
when they were applied separately (Fig 9B,C). Thus, when compared to the CCh alone response, 
there was a sharper increase in Ca2+ in responding cells followed by an elevated phase which had 
a higher amplitude than in CCh alone. [Ca2+] remained elevated (Fig 9B, right plot).  
The change in characteristics of the Ca2+ response occurred in individual cells (Fig 9C) i.e. the 
change was not a consequence of an analysis that averaged responses across cells. In Fig 9C the 
responses of 3 separate cells to CCh, ATP and both agonists are shown – it is the same 3 cells in 
each case. Cell 1 (Fig9C left-panel) responds to CCh but not to ATP. While the cell des not 
respond to ATP with a Ca2+ change, the characteristics of the response to CCh is altered when 
ATP is also present (combined) and there is a faster and larger upstroke. Cell 2 (Fig 9C middle-
panel) responds to ATP but not CCh. The characteristics of the response in Cell 2 to ATP is 
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altered when CCh is also present (combined) and there is a smaller initial peak and a more 
sustained later Ca2+ change. Cell 3 (Fig 9C right-panel) responds to CCh and to ATP. Once again 
the characteristics of the response in Cell 3 is altered when ATP and CCh both are present. The 
reduced rapid initial spike to ATP, when both agonists were present, may have occurred because 
those cells that responded to ATP were sensitive to CCh though not Ca2+ responsive to the 
agonist. 
The combined response that occurred when both agonists were present was neither the mean nor 
a linear summation of the individual responses. The mean peak to CCh and ATP when both 
agonists were present (combined) exceeded the mean response to CCh and ATP when they were 
applied separately and was less than the summed response (Fig 9D). The combined steady-state 
response exceeded both the mean and the summed response to the EC25 of CCh and ATP when 
applied separately (Fig 9E).  These results suggest the precise nature of the computation carried 
out when both agonists are present is not clear but appears to be non-linear for both the peak and 
steady-state response and in the case of the steady-state response, expansive, in that the 
combined response exceeds linear summation of each input. 
Communication among cells  
The new composite Ca2+ signals that arose when both agonists were present may have occurred 
because cells are sensitive to both activators but sub-threshold to one or because signals from 
each agonist are communicated from other cells to the cell in which the composite behavior was 
seen.  Both possibilities appear to exist. 
To determine if communication occurred, we first identified cells that were largely unresponsive 
to one activator at each of the EC25 and EC75 concentrations from a field of endothelium (Fig 
10A-D). Figure 10C,D shows an example cell in which the response to CCh at the EC25 or EC75 
was small and had little concentration dependent increase indicating subthreshold behavior. This 
same cell responded strongly to ATP (Fig 10D). The response to ATP (EC25) was a small Ca2+ 
peak which decline towards resting values. ATP (EC75) evoked a larger transient rise, which 
declined to a small sustained elevation in baseline. Interestingly, while the cell responded weakly 
to CCh, nonetheless, CCh (EC25) substantially altered the response to ATP (EC25). At the EC25 of 
ATP when the CCh (EC25) was also present, there was a larger and more sustained elevation in 
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Ca2+ with oscillations, than when ATP (EC25) alone was present.  Since responses to the EC25 
and EC75 of CCh was at best weak, the modification of the response to ATP (EC25), when the 
EC25 of CCh was present, is consistent with the cell responding directly to ATP (EC25) while 
receiving signals from neighboring CCh-sensitive cells.  
Some cells are sensitive to both activators. We found in those cells, the Ca2+ response was 
distinctive to each agonist (Fig 9C) i.e. CCh (EC25) still evoked repetitive Ca2+ oscillations on an 
elevated baseline value while a low concentration of ATP (EC25) evoked a rapid rise in Ca2+ 
followed by a decline back to resting values. This observation suggests that the distinctive 
different features of the Ca2+ signals evoked by each agonist were linked to the agonist rather 
than the cell. 
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Discussion 
A major challenge faced by the endothelium is the need to process an enormous quantity of 
information held in the complex chemical environment to which the vascular system is exposed. 
From this information decisions on physiological outputs are made. The endothelium uses a 
multitude of receptors to continuously monitor vanishingly small changes in the concentration of 
extracellular signals (2-5, 42) that each provides cues to the ever-changing physiological state.  
Extracellular signals must be accurately detected and correctly relayed via intracellular Ca2+ 
signals so that information is not lost. Precisely how the endothelium processes the entire 
chemical composition to which it is exposed and transduces multiple extracellular signals, to 
specific cell activities is not fully understood.  We have shown the endothelium uses spatially-
structured arrangements of cells that extract small separate components of the overall 
information content. These components evoke distinctive Ca2+ and nitric oxide signals in specific 
clusters of cells. The Ca2+ signals are shared among cells. When more than one stimulus is 
present, computations are carried out on the input signals to generate new signals that are a 
composite of each input signal. The endothelium thus detects signals in a noisy environment by 
using cells that are not concerned with all possible available information but with only a small 
part of the overall content. These cells then collaborate with network partners in the distribution 
and integration of information.  
The endothelium has a very large functional repertoire and controls virtually every 
cardiovascular function.  Dysfunction of the endothelium underlies almost all cardiovascular 
disease. The short range network properties may determine the endothelium’s sensing abilities 
and the effectiveness of information transfer. Despite the diverse functional activities of the 
endothelium, the anatomy and connectivity of the cells and network are largely fixed (each cell 
has 6 neighbors).  The question of how a large functional signaling repertoire arises from a fixed 
anatomy and connectivity using a single communication signal (Ca2+) both within and between 
cells is unresolved. Most studies on the endothelium provide information derived from large 
ensemble measurements in intact arteries or cultured cell models in which the behavior of the 
population is assumed to be uniform. When communication between cells is believed to occur, 
information arriving at one cell is thought to be conveyed to neighboring cells (e.g. other 
endothelial cells) without changing the information content much like signaling in a cable (11, 
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12). We developed an approach that provides an independent readout of hundreds of individual 
endothelial cells in intact arteries. The findings show there is divergence between structural and 
functional networks. While the endothelium has a defined, fixed, network architecture, responses 
to different extracellular signals are organized into separate local clusters or interactions of  that 
network to ensure efficient message detection and for multiple simultaneous stimuli to be 
accommodated.  
Our results show the response throughout the endothelium was not uniform and various regions 
selectively responded to different activators. In those regions, endothelial cells that activate to an 
agonist were found to be significantly more closely spaced (clustered) than expected if the 
agonist response was randomly distributed across cells. Different agonists activated different 
clusters of cells in separate regions or the endothelium. The clustering of cells with 
responsiveness to particular agonists may offer several advantages. Clustering may provide a co-
incidence detection system to help improve signal detection (8). It is also tempting to speculate 
that clustering may allow the uptake and breakdown mechanisms for diffusible messengers (e.g. 
nitric oxide, prostaglandin) to be overwhelmed providing increased spillover of signals. 
Clustering may limit the interference from neighboring cells that are responding to a different 
stimulus. i.e. a single cell responding in isolation may easily be influenced by neighboring cells 
and have its signal overridden. A cluster performing the same task may be much harder to 
override. The mechanisms giving rise to the organization of cells into clusters are not yet clear 
but perhaps self-replication occurs during development or there is feedback control of function 
and receptor expression based on location or a result of a self-organization process at the cellular 
level. 
In other studies various receptors have been reported to be heterogeneously distributed in the 
endothelium (43). The distribution of angiotensin II immunostaining is irregular in neighboring 
endothelial cells of femoral mesenteric artery (44). ACh-evoked Ca2+ responses are larger at 
branches in rat thoracic aorta than that of nearby non-branch regions (38). The reverse was true 
of histamine (38). The sensitivity to histamine and ACh was not distributed evenly among 
neighboring cells but arranged in ‘belts’ of high sensitivity that varied by ~100 fold along the 
flow lines (38). In studies of murine thoracic aorta endothelial cells, while most cells (82%) 
responded to ATP, large fractions of cells did not respond to ACh, bradykinin or substance P 
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(45). A mosaic pattern of micro-domains of VWF-positive and -negative endothelial cells occur 
in the capillaries of many vascular beds and in the aorta (6, 44, 46). Our results also show there is 
heterogeneity in the distribution of receptors (M3 and P2Y2) which offers and explanation for 
the heterogeneous responses. Single-cell profiling of primary endothelial cells revealed  
surprisingly high level of heterogeneity and patterning of G-protein coupled receptor expression 
in subpopulations of cells  (47). While appreciated to exist, the physiological significance of the 
various receptor distributions and sensitivities and has not been understood. The heterogeneity in 
the distribution of receptors and clustering of sensing cells may be central to the function of the 
elaborate sensing system operating in the endothelium.  
Many (13-16, 29) though not all (20) extracellular activators are transduced to changes in 
intracellular Ca2+ concentration to evoke specific cell activities. An unresolved question in Ca2+ 
signaling is how this single ion can selectively control virtually all cellular processes. Our data 
shows that Ca2+ signals evoked by low but equivalent (EC25) concentrations of CCh and ATP in 
separate cells are distinctive. CCh evokes a small persistent rise in Ca2+ while ATP evokes an 
initial Ca2+ spike followed by a decline to basal values i.e. there is an input/output relationship 
between agonist and signal that is temporally-distinctive. When the agonists are applied 
separately at moderate concentrations (EC25), most cells are sensitive to only one agonist 
(unimodal cells). However, some cells are sensitive to both (multimodal cells). Importantly, 
when the agonists are added separately, multimodal cells generates distinctive signals to each 
agonist. This observation suggests that the distinctive signals evoked by each agonist are a 
feature of the agonist acting on the cells rather than the cell itself. 
When both agonists are present, a new signal output is generated that is distinct from each of the 
signals generated when the agonists are present separately. The generation of a new signal 
suggests that cells perform computations by combining information from each source to produce 
a new output. At least two mechanisms may give rise to the new distinctive signal. First, some 
cells (multimodal) possess receptors for both activators so a summation/averaging of activation 
of individual responses within these occurred. Alternatively, unimodal cells may be directly 
activated by only one agonist, and receive signals from another cell that is receptive to a different 
agonist. To test for the possibility that cells also received signals from other cells we examined 
signals in (the few) cells responded to neither the EC25 or EC75 of one agonist. Importantly, in 
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those cells that did not respond to one agonist (even at the EC75) there was nonetheless 
modification of the signals to the other agonist when both were present at the EC25. It seems 
likely that cells received signals (Ca2+ or IP3) from neighboring cells to modify responses when 
both agonists were present. 
Taken together these results suggest that different stimuli evoke distinctive signals in endothelial 
cell, that the input/output relationship for a given cell and agonist is not fixed and that cells act as 
computational elements when more than one signal is present. The precise nature of the 
computation is not clear but it appears that it is not a simple summation or averaging of each 
separate signal. In the case of the steady-state response, the computation appears to be non-linear 
and expansive in that the combined response exceeds linear summation of each input. The 
computation is a feature emerging from the collective dynamics of the endothelial network and 
provides a mechanism for the endothelium to interactively monitor external environments via 
sensing that is distributed on across separate cells. This arrangement may give rise to the diverse 
function in the endothelium arising from a fixed network structure that communicates using a 
single signaling molecule (Ca2+). 
The cardiovascular system undergoes continuous bombardment from a multitude of chemical 
instructions providing information on physiological status. Most signals are generated to evoke 
the continuous routine but small adjustments to cardiovascular function. As a result, many of the 
signals are of a very small magnitude and sit on a baseline concentration that is noisy and close 
in value to the normal peak increase (2-5). The normal daily concentration changes of circulating 
hormomes, such as parathyroid hormone, epinephrine, angiotensin II or leptin, is vanishing small 
and vary from a resting value of a few tens of picomolar to a peak increase in the low hundreds 
of picomolar (2-5, 42). The endothelium acts as the interface for the information and must detect 
the signals and decode an enormous quantity of data held in multiple signals to direct resources 
to the most behaviorally-relevant cardiovascular activity. The endothelium must also quickly 
redirect resources when faced with rapid physiological changes involving much higher local 
concentration changes such as those occurring during a bleeding event. The mechanisms by 
which the endothelium is capable of merging multiple agonist of varying concentration 
magnitudes are unknown. The data in the present study suggests that the processing of multiple 
chemical instructions is not achieved by each cell sensing every instruction but from the separate 
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activity of a collective of endothelial cells. Various endothelial cells encode only certain aspects 
of the overall information content. Communication of information among connected cells allows 
the endothelium to merge information and provide a more comprehensive “picture” of 
physiological status. Together, the observations suggest sensing and control is distributed among 
a number of endothelial cells and that spatial-structuring of sensory cells and temporal-encoding 
of signals is fundamental to endothelial signal detection. As a collective the endothelium can 
efficiently process multiple instructions and act as a sensory system that has substantially greater 
computational power than the capabilities of any single cell.   
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Materials and Methods 
Animals 
All animal care and experimental procedures were carried out with the approval of the University 
of Strathclyde Animal Welfare and Ethical Review Board (Schedule 1 procedure; Animals 
(Scientific Procedures) Act 1986, UK), under UK Home Office regulations. All experiments 
utilized freshly isolated rat carotid arteries obtained from male Sprague–Dawley rats (10–12 
weeks old; 250–350 g) killed by intraperitoneal overdose of pentobarbital sodium (200 mg kg-1, 
Pentaject, Merial Animal Health Ltd, UK) CO2 overdose. 
En face artery preparation 
Endothelial Ca2+ signaling was imaged in en face carotid artery preparations (31). Arteries were 
cut open along their longitudinal axis, using microscissors, and pinned out on a Sylgard block, 
with the lumen side upward. Endothelial cells were incubated with a physiological saline 
solution (PSS) containing the fluorescent Ca2+ indicator, Cal-520 acetoxymethyl ester (Cal-
520/AM) (5μM), 0.02% Pluronic F-127 and 0.35% DMSO for 30 min at 37°C. After incubation 
the arteries were gently washed with PSS at room temperature and allowed to equilibrate for 30 
minutes. The Sylgard block containing the artery was placed in a custom bath chamber that was 
fixed to the stage of an inverted fluorescence microscope (TI-E; Nikon, UK). The bottom of the 
bath chamber was a 0-grade thickness microscope coverslip. Two 200 μm pins were used to raise 
the Sylgard block from the coverslip so that the endothelium did not contact the glass coverslip 
and permitting solutions to be flowed through the chamber. Laminar flow was provided by a 
syringe pump that was connected to the chamber via silicone tubing. Solutions were flowed into 
the bath at a rate of 1.5 ml/min.  
Cal-520/AM was excited with 488 nm excitation light provided by a monochromator (Photon 
Technology International/Horiba UK, Ltd., UK) and imaged using a back-illuminated electron-
multiplying charge coupled device (EMCCD) camera (iXon3; Andor, Belfast, UK; 13 μm pixel 
size) through a 40X (oil immersion; numerical aperture 1.3; Nikon S Fluor) objective lens (48, 
49). Fluorescence emission was recorded at 10 Hz. Fluorescence illumination was controlled and 
images (16-bit depth) captured using WinFluor (WinFluor, University of Strathclyde, Glasgow, 
UK). Following each pharmacological activation, the preparation was washed with PSS for 5 
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minutes and then allowed to rest for a further 5 minutes to ensure a stable baseline was 
established before subsequent drug applications. 
Cholinergic and Purinergic Ca2+ Signaling 
Endothelial Ca2+ signaling was examined in response to muscarinic and purinergic agonists.  Full 
non-cumulative concentration responses were obtained in each en face preparations by applying 
each of the agonists at various concentrations (CCh from 1 nM to 30 µM; ATP 100 nM to 1mM). 
Only one concentration-response curve was generated per carotid artery preparation.  
In experiments designed to analyze the first responding cells (at EC25 and EC75 concentrations) 
the agonists were sequentially applied to the same artery preparation and recordings were made 
from the same field of endothelium for the EC25 and EC75 concentrations for both agonists. The 
EC25 and EC75 values were obtained from concentration-response curves showing the 
‘percentage of active cells’. Both agonists were then applied simultaneously, at the EC25 
concentration, to the same artery to determine any interaction between the two agonists in the 
cells activated. 
In experiments designed to determine the receptor subtype involved in CCh evoked Ca2+ 
signaling a selective M3 antagonist 4-DAMP (100 nM) was used. To determine whether 
metabotropic or ionotropic receptors were involved in ATP evoked Ca2+ signaling, ATP was 
applied to the endothelium in Ca2+-Free PSS. Specific P2Y1 receptor antagonist (MRS2179; 10 
µM) and P2Y2 receptor antagonist (ARC118925; 1 uM) were used to discern the metabotropic 
receptor subtype involved in ATP evoked Ca2+ signaling. 
Automated Ca2+ signal analysis 
Due to the large number of cells imaged, manual analysis of each individual cell was impractical. 
Therefore, automated analysis software (WAVE; Whole-cell AVErage) was used to extract Ca2+ 
signals from every cell in the field-of-view (Wilson et al., 2016). In brief, (1) all cells within the 
field-of-view are identified and a region of interest (ROI)  that encompasses the cell area is 
created; (2) the Ca2+ signals from each ROI are extracted as time-dependent fluorescence 
intensities (3) each Ca2+ signal is normalized to its corresponding baseline; (4) Ca2+ signaling 
metrics, such as peak amplitudes and oscillation frequency, are rapidly and objectively 
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determined for all cells (ROIs); and (5) Ca2+ signals and summary data are presented in pictorial 
form. The Ca2+ signal from precisely the same cell can be matched across different experiments. 
ROI Generation 
Intensity thresholding of the raw image does not yield accurate cellular ROIs due to the high 
density of endothelial cells in intact arteries. Instead, average intensity projections were 
sharpened using an unsharp masking macro written in ImagePro (Schindelin et al., 2012). After 
sharpening, individual cellular ROIs were obtained by intensity thresholding (in ImagePro) and 
manually splitting any ROI that overlapped two (or more) cells. To enable a comparison (i.e. 
pairing) of the response of individual cells after various treatments during an experiment, cellular 
ROIs were generated from a single control dataset were applied to all responses obtained in that 
single experiment. Where slight tissue movement occurred between acquisitions, ROI’s were 
aligned across individual datasets using an automated alignment plug-in in FIJI (Schindelin et 
al., 2012). Each ROI (Cell) was assigned an individual number (Cell #) for identification 
throughout and enable a direct comparison of the same cell in response to different treatments.  
Automated whole-cell Ca2+ signal extraction 
Ca2+ signals were calculated for each individual cell from the Cal-520/AM fluorescence intensity 
within each ROI. Each signal was expressed as baseline-corrected fluorescence intensity (F/F0), 
where F is fluorescence at time, t, and F0 is basal fluorescence intensity. F0 was determined for 
each individual ROI by averaging a 100-frame (10 second) baseline period at the start of each 
recording. F/F0 traces were smoothed using 11-point (1.1 s), third-order polynomial Savitzky–
Golay filter.  
Automated whole-cell Ca2+ signal analysis 
Endothelial Ca2+ signals exhibit oscillatory behavior. The occurrence of these oscillations was 
identified automatically using the discrete (first) derivative (d(F/F0)/dt) of the Ca2+ signal (F/F0). 
Discrete derivate signals were calculated by convolving F/F0 traces with the first derivative of a 
Gaussian kernel in the programming language, Python (8, 50). An increase in F/F0 corresponds 
to a positive deflection in the discrete derivative and a decrease in F/F0 corresponds to a negative 
deflection in the discrete derivative. At the peak of an F/F0 Ca2+ spike the derivative changes 
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sign from positive to negative. A ‘zero-crossing detector’ was used on the discrete derivative to 
identify the time at which peaks occurred in the F/F0 data i.e. when the sign of the rate changed 
from positive to negative and the rate of change is zero. The zero-crossing detector provided a 
list of times of ‘zero-crossing’ – i.e. the times at which a peak occurs in the data. Therefore, the 
zero-crossing detector enabled the times of all peaks, with a magnitude greater than 10-times the 
standard deviation of baseline noise (considered to be the threshold), in the derivate signal to be 
extracted. Those times were then used to extract conventional measurements (e.g. amplitude) 
from the corresponding F/F0 data. The detection of a peak from the discrete derivative trace 
(above threshold) was used to determine if a cell responded. If a peak was detected in a cell, the 
cell was defined as being ‘active’.  Oscillatory Ca2+ signals evoked by the agonists were 
measured in terms of peak amplitude of the initial Ca2+ rise, the response averaged over 60-
seconds following this peak, and percentage of the total number of cells which responded. The 
times of occurrence of the first peak in each Ca2+ response were used to generate latency profiles 
of cellular Ca2+ responses. These latency profiles are presented as histograms with time, t = 0, 
corresponding to the time of the first detected peak. 
Ca2+ responses were recorded over a five-minute period. This allowed for the recording of basal 
Ca2+ activity (no agonist; ~1-2 minutes) and the response to stimuli (~3-4 minutes)  
Cell Clustering and Neighbor Analysis 
In order to examine the spatial relationship of cell responses, a robust means to define spatial 
relationships between cells was required.  For this purpose we used a modification of a Voronoi 
tessellation (51, 52).  Briefly, the center coordinates of each biological cell’s nucleus forms a 
vertex in a Voronoi tessellation.  The tellsellation partitions the image space into a series of 
Voronoi cells.  Each Voronoi cell contains all points closer to its vertex than to any other vertex.   
Each edge in the Voronoi diagram separates two Voronoi cells and represents all points in space 
equidistant to the coordinates of the two nuclei that define the two Voronoi cells, and that are 
closer to those nuclei than to any other.   We use each edge in the tessellation to define the 
corresponding biological cells to be “Voronoi neighbors”. Voronoi tessellation and subsequent 
analysis was carried out in the Python language version 2.7.11 using the scipy (53) and numpy 
(54) libraries, versions 0.17.0 and 1.10.4 respectively. 
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Nitric oxide imaging and analysis 
Arteries were pinned flat in a custom made bath chamber and pre-loaded with Cal-520 as 
described above to identify endothelial cell positions. To measure nitric oxide production arteries 
were then incubated in HANKS buffer solution containing DAR-4 AM, a cell permeable nitric 
oxide reporting fluorophore (100 µM DAR-4M AM, 0.02% Pluronic F-127 and 100 µM L-
arginine) for 30 minutes at room temperature. After incubation arteries were gently washed with 
HANKS buffer and allowed to equilibrate for 30 minutes. Laminar flow was provided by a 
syringe pump that was connected to the chamber via silicone tubing. Solutions were flowed into 
the bath at a rate of 1.5 ml/min. DAR-4M AM was excited using 550 nm wide-field 
epifluorescence illumination provided by a monochomator (Photon Technology 
International/Horiba UK, Ltd., Stanmore, United Kingdom) and visualized using a back-
illuminated electron-multiplying charge coupled device (EMCCD) camera (iXon Life 888; 
Andor, Belfast, UK; 13 μm pixel size) through a 60X (water immersion; numerical aperture 1.0; 
Nikon S Fluor) objective lens. Fluorescence emission was recorded at 10 Hz. Fluorescence 
illumination was controlled and images (16-bit depth) captured using µManager software 
(Edelstein et al. 2010). Following each pharmacological activation (with CCh or ATP), the 
preparation was washed with HANKS buffer for 10 minutes and then allowed to rest for a further 
10 minutes to ensure a stable baseline was established before subsequent drug applications. 
Automated analysis was carried out as described above to calculate the nitric oxide production 
for each individual cell. ROI’s were generated using the Cal-520 loading, imaged at 488 nm. 
Nitric oxide production was recorded over a five-minute period. This allowed for the recording 
of basal nitric oxide activity (no agonist; ~1-2 minutes) and the response to stimuli (~3-4 
minutes). 
Endothelial Immunocytochemistry  
Arteries were pinned to a 6 well plate containing Sylgard and fixed in 4% Paraformaldehyde for 
20 minutes at room temperature. Arteries were washed 3 times in 100 µM glycine solution 
followed by 3 washes with PBS, permeabilzed with 0.2% Triton-X100 in PBS for 10 minutes 
and washed again 3 times with PBS. Arteries were then incubated in Antibody Buffer solution in 
PBS for 1 hour at room temperature then washed 3 times with Antibody wash solution 
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containing 5% BSA. The arteries then were incubated with a rabbit anti-P2Y2 receptor antibody 
(1:100, sc-20124, Santa Cruz, Dallas, TX, USA) and CD31 (1:200, AF3628, R&D Systems,) in 
PBS containing 1% BSA and 2% Donkey Serum for 12 hours at 4°C. Arteries were washed with 
Antibody wash solution containing 5% BSA 3 times followed by incubation with Alexa Fluor 
488 donkey anti-rabbit antibody (Invitrogen, Carlsbad, CA, USA) and Alexa Fluor 568 donkey 
anti-goat antibody (Invitrogen, Carlsbad, CA, USA)  in Antibody Buffer Solution for 1 hour at 
room temperature. The P2Y2 Receptor Antibody was excited using 488 nm and CD31 Antibody 
was excited using 568 nm wide-field epifluorescence illumination provided by a monochomator 
(Photon Technology International/Horiba UK, Ltd., Stanmore, United Kingdom) and visualized 
using a back-illuminated electron-multiplying charge coupled device (EMCCD) camera (iXon 
Life 888; Andor, Belfast, UK; 13 μm pixel size) through a 60X (water immersion; numerical 
aperture 1.0; Nikon S Fluor) objective lens. Fluorescence emission was recorded at 10 Hz. 
Fluorescence illumination was controlled and images (16-bit depth) captured using ImageJ 
(National Institutes of Health, Bethesda, MD, USA). Negative controls were performed in the 
absence of primary antibody. 
Fluorescent Ligand Binding in Intact Endothelium 
To visualize P2Y2 Receptors and M3 Receptor distribution, P2Y2-antibody stained arteries were 
loaded with a Fluorescent Muscarinic M3 receptor Antagonist (M3-633-AN, 100 nM; Sigma-
Aldrich) for 20 minutes at room temperature. The Fluorescent Muscarinic M3 receptor 
Antagonist was excited at 633 nm and visualized as described above. Negative controls were 
performed in the presence of the selective M3 receptor antagonist 4-DAMP (10 µM, 20 minute 
incubation before Fluorescent Muscarinic M3 receptor Antagonist loading). P2Y2, M3 and 
PECAM visualization was carried out in precisely the same area of endothelium by changing the 
excitation wavelength.  
Cell boundaries were identified using PECAM-1 fluorescence. From these boundaries ROI’s 
were manually extracted to identify individual endothelial cells. The area of M3, P2Y2 
expression and the extent of co-localization (M3 and P2Y2 overlap) were then determined within 
each cell (using the ROIs) and from the full field of view using ImageJ.  
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P2Y2 Receptor Antibody Validation 
Specificity of the antibody for P2Y2 receptors (sc-20124, 1:100, Santa Cruz, Dallas, TX, USA) 
was confirmed in experiments carried out in cell lines that either (1) completely lack P2Y 
receptors or (2) express only P2Y2 receptors (Supplementary Fig S7).  1321N1 cells (ECACC 
Cat# 86030402, RRID:CVCL_0110) are a human astrocytoma cell line that does not 
endogenously express any of the eight P2Y receptor subtypes or respond to the naturally-
occurring nucleotide agonist (41) and were used as a negative control for the antibody. 1321N1 
cells stably expressing recombinant human hP2Y2 receptors (1321N1-hP2Y2)(40) were used as 
a positive control (Supplementary Fig S7). 
Wild-type 1321N1 cells and 1321N1 cells stably expressing recombinant human hP2Y2 
receptors (1321N1-hP2Y2) (40) were maintained in 5% CO2, 95% O2 in a humidified incubator 
at 37°C, in Dulbecco’s Modified Eagles Media (Life Technologies, Paisley, UK, catalogue 
number 21969-035), supplemented with 10% foetal calf serum, 1% non-essential amino acids, 
1% penicillin (10,000 units/ml) and streptomycin (10 mg/ml). 
The wild-type 1321N1 cells and 1321N1 cells stably expressing recombinant human hP2Y2 
receptors (1321N1-hP2Y2) were fixed in 4% Paraformaldehyde for 20 minutes at room 
temperature and washed 3 times in 100 µM glycine solution followed by 3 washes with PBS. 
Cells were then incubated in Antibody Buffer solution in PBS for 1 hour at room temperature 
then washed 3 times with Antibody wash solution containing 5% BSA. The cells were then 
incubated with a rabbit anti-P2Y2 receptor antibody (1:100, sc-20124, Santa Cruz, Dallas, TX, 
USA) in PBS containing 1% BSA and 2% Donkey Serum for 2 hours at 4°C. Cells were washed 
with Antibody wash solution containing 5% BSA 3 times followed by incubation with Alexa 
Fluor 488 donkey anti-rabbit antibody (Invitrogen, Carlsbad, CA, USA) in Antibody Buffer 
Solution for 1 hour at room temperature. The P2Y2 Receptor Antibody was excited using 488 
nm wide-field epifluorescence illumination provided by a LED ( CoolLED pE-300ultra, CoolLED 
Ltd, Andover, UK) and visualized using a back-illuminated electron-multiplying charge coupled 
device (EMCCD) camera (iXon Life 888; Andor, Belfast, UK; 13 μm pixel size) through a 40X 
(oil immersion; numerical aperture 1.3; Nikon S Fluor) objective lens. Fluorescence emission 
was recorded at 10 Hz. Fluorescence illumination was controlled and images (16-bit depth) 
captured using ImageJ (National Institutes of Health, Bethesda, MD, USA). Cells were incubated 
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in PBS containing 0.5mg/ml DAPI to visualize the nucleus of endothelial cells. DAPI was 
excited at 365 nm and visualized as described above. 
P2Y2 receptor distribution was quantified as fluorescence intensity levels. Since there was an 
almost complete absence of staining in 1321N1 cells (which lack P2Y receptors) full field 
fluorescence was measured. Cell nuclei counts using DAPI staining ensured comparable cell 
number in wild-type and P2Y2 expressing cells. 
Pressure Myography 
The left and right common carotid arteries were exposed by sharp dissection and both arteries 
were extracted and placed in HANKS buffer solution. Under a stereomicroscope arteries were 
cleaned of connective tissue and visually checked for the presence of side branches. Arteries 
without side branches were mounted onto two blunted, sterile 25G x 5/8” BD Microlance 
Needles (0.51mm Outer Diameter) using silk suture thread, in a self-heated single vessel 
chamber (CH-1-AU-SH, Living Systems Instrumentation, Albans City, VT, USA). Arteries were 
gently heated to 37°C and allowed to equilibrate for 30 minutes. The proximal end of each BD 
Microlance Needle was connected to a separate syringe containing HANKS buffer solution. The 
height of two syringes was adjusted to alter the transmural pressure of the arteries. The pressure 
was increased in 10 mmHg increments with 10 minute equilibration allowed before subsequent 
increases in pressure.  When a final pressure of 110 mmHg was attained arteries were allowed to 
equilibrate for 30 minutes. During equilibration arteries were tested for leaks (which may 
indicate branches in the vessel wall or insufficiently tied sutures) by stopping the flow of 
solution from the syringes to the arteries by switching the valves connecting the syringes to the 
BD Microlance Needles. This allowed the pressure within the arteries to remain constant. 
Arteries that showed a reduction in pressure were discarded. HANKS buffer was circulated in 
the chamber that contained the arteries at 10 ml/min using a peristaltic pump from a reservoir 
(heated to 37°C). 
To determine the vasorelaxant effects of CCh and ATP, arteries were first contracted using 
phenylephrine (100 µM), applied to the outside of the artery by adding the agonist to the 
reservoir and allowing it to circulate. Arteries were then allowed to equilibrate to ensure a stable 
contraction was achieved before subsequent drug applications. CCh or ATP were applied to the 
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arteries intraluminally. To do this, the height of one syringe was adjusted to allow gravitational 
flow (0.5 ml/min) of solution through the lumen of the artery. CCh (100 µM) was applied by 
adding the drug to the higher of the two syringes that perfused the artery lumen. Arteries were 
then allowed to equilibrate for 20 minutes (10 minutes for the drug to reach the lumen; 10 
minutes of activation). Following activation, the solution in the syringe was removed and 
replaced with HANKS buffer. Arteries were washed intraluminally with HANKS buffer until 
arteries returned to a contracted state. ATP (100 µM) was subsequently applied to the same 
artery, as described above.  
In experiments designed to determine endothelial Ca2+ dependence of CCh- and ATP-mediated 
vasodilation, BAPTA-AM (30 µM), a cell-permeable selective Ca2+- chelator was applied 
intraluminally as described above. Preconstricted arteries were allowed to equilibrate in BAPTA-
AM for 30 minutes prior to the addition of CCh (100 µM) and ATP (100 µM).  The effects of the 
Ca2+ chelator (BAPTA) on CCh and ATP evoked relaxation was compared to internal controls 
with each vasodilator carried that were out in the same artery. 
Artery images were recorded using a CMOS camera (DCC1545; ThorLabs Inc. Newton, New 
Jersey, USA; 5.2 μm pixel size) through a 2.5X (air; numerical aperture 0.06; Zeiss A-Plan) 
objective lens. Images (8-bit depth) were captured using µManager software (55). 
Drugs and solutions 
Cal-520/AM was obtained from Abcam (Cambridge, MA, USA). Pluronic F-127 was obtained 
from Invitrogen (Carlsbad, CA, USA). AR-C 118925XX and MRS 2179 were obtained from 
Tocris (Abingdon, UK). P2Y2 Antibody (H-70) was obtain from Santa Cruz (Dallas, TX, USA ). 
CD31/PECAM-1 antibody was obtained from R&D Systems (Minneapolis, MN, USA). All other 
drugs and chemicals were obtained from Sigma (St Louis, MO, USA). The PSS consisted of 
(mM): 145 NaCl, 4.7 KCl, 2.0 MOPS, 1.2 NaH2PO4, 5.0 glucose, 0.02 EDTA, 1.17 MgCl2, 2.0 
CaCl2, adjusted to pH 7.4 with NaOH. The Ca2+-Free PSS consisted of (mM): 145 NaCl, 4.7 
KCl, 2.0 MOPS, 1.2 NaH2PO4, 5.0 glucose, 0.02 EDTA, 1.0 EGTA, 2.34 MgCl2, adjusted to pH 
7.4 with NaOH. HANKS buffer consisted of (mM): 125 NaCl, 5.4 KCl, 4.2 NaHCO3, 0.4 
KH2PO4, 0.3 NaH2PO4, 10 HEPES 10.0 glucose, 1.17 MgCl2, 2.0 CaCl2, adjusted to pH 7.4 with 
NaOH. Antibody Buffer solution consisted of: 0.05% Triton-X100, 0.02% Sodium Azide, 5% 
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SSC (20X). Antibody wash solution consisted of: 5% SSC (20X), 0.05% Triton-X100, 5% BSA. 
All solutions were freshly prepared daily. 
Statistics 
The data are presented as mean ± SEM values; n refers to n arteries obtained from n different 
animals (biological replicates). For comparison of two groups, a Student's t test (paired data) or 
unpaired t-test (unpaired data) was performed. All statistical analyses were performed using 
GraphPad Prism, version 6.0 (GraphPad Software, La Jolla, CA, USA). p < 0.05 was considered 
statistically significant. 
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Supplementary Materials 
Supplementary Fig S1 CCh evoked Ca2+ signals in the endothelium. 
Supplementary Fig S2  Flow-induced endothelial Ca2+ signaling 
Supplementary Fig S3 Endothelial Ca2+-dependence of endothelial-evoked dilation  
Supplementary Fig S4 Concentration-dependence of the CCh-evoked endothelial Ca2+ response. 
Supplementary Fig S5 Concentration-dependence of the ATP-evoked endothelial Ca2+ response. 
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Figure Legends 
Figure 1 - CCh evoked Ca2+ signals in the endothelium of intact arteries. (A) Ai 
Representative image frame showing ~200 endothelial cells from an imaging field. (Aii) An 
image of cells with automatically identified regions of interest (ROI) superimposed onto the 
imaging field of view. (Aiii) Ca2+ images illustrating the endothelial response during treatment 
with CCh (100nM) overlaid on a basal Ca2+ image. (B) Expanded view of the endothelium 
from the area highlighted in the red box in (A). (C) Baseline-corrected Ca2+ signals (F/F0) 
obtained from the fluorescence within the ROI shown in (B). The color for each trace matches 
that presented in the ROI in B. The fluorescence amplitudes are scaled in the same way for 
each cell. (D) Overlaid Ca2+ signals from all individual cells identified in Aii. The black line 
shows the mean response (E) An example single endothelial cell Ca2+ signal and the 
corresponding images shown in F with time-points indicated by the roman numerals (E,F). 
Scale bars = 50µm 
Figure 2  Concentration-dependence of CCh-evoked endothelial Ca2+ signaling. (A) 
Representative composite images of endothelial Ca2+ activity in response to increasing 
concentrations of CCh. The three images show illustrative data from a single artery in which the 
endothelium was stimulated with consecutively increasing concentrations of CCh. The full series 
applied in each experiment was 10 increments from 1 nM to 30 µM. Scale bars = 50µm. (B) 
Average Ca2+ (F/F0) responses from all cells for each concentration of the full series. The 
individual traces are color-coded based on the concentration of CCh applied. (C) Ca2+ traces 
from a single cell. The color code is the same as shown in B. (D) Percentage of cells activated by 
increasing concentrations of CCh. The x-axis is log10 of the CCh concentration. (E) Ca2+ traces 
from all 129 individual cells from the datasets shown in A. The black line is the mean response. 
The other colors assigned to each trace is based on the amplitude of the initial response to CCh in 
each cell at the highest CCh concentration (right-most dataset), i.e. if a cell’s trace is colored 
blue in one set of traces, the same trace in the other two data sets is also colored blue. The color 
of each specific cell’s trace is maintained throughout subsequent additions of agonist allowing 
for a direct comparison of the same cells between responses 
Figure 3 CCh activates M3 receptors in the endothelium (A) Representative experiment 
(average of all cells) showing the effect of the selective M3 antagonist 4-DAMP (100 nM). The 
endothelium was activated by CCh at a concentration (100 µM) evoking a maximum response. 
Two control responses show approximately reproducible responses. CCh application is indicated 
by the line above the traces. 4-DAMP inhibits the response. After block of M3 receptors, the 
cells remain viable and respond to ATP (100 µM; right-hand trace). (B) Composite Ca2+ images 
showing the cells that respond to CCh (100 µM; green) and an absence of response after the 
block of M3 receptors by 4-DAMP (100 nM). The subsequent application of ATP (100 µM) 
evoked a response (red). All images are from the same field of endothelium. (C) Ca2+ signals 
from all activated cells in B, 30s baseline and 60s activation. Responses are overlaid and the 
black line is the average. (D) Paired peak Ca2+ (F/F0) responses from each individual cells 
(circles) matched for each treatment (grey line) from a single experiment. Average response 
indicated by white circle and matched across each treatment by bold line. The Plotting Density 
(right axis) indicates the distribution of Peak F/F0 values (red high, blue low occurrence of the 
same value). (E) Paired summary data illustrating changes in Peak F/F0 response values averaged 
across all cells (n=5). All Scale bars = 50µm. p < 0.05 
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Figure 4 Concentration-dependence of ATP-evoked endothelial Ca2+ signaling. (A) 
Representative composite images of Ca2+ activity in carotid artery endothelium in response to 
stimulation with increasing concentrations of ATP. The three images show illustrative data from 
a single experiment in which the endothelium was stimulated with consecutively  increasing 
concentration of ATP (from 100 nM to 10 mM). Scale bars = 50µm. (B) Average Ca2+ (F/F0) 
responses from all cells in (A). The data shows responses to each concentration of the full series 
shown in A. The individual traces are color-coded based on the concentration of ATP applied 
(inset). (C) Ca2+ traces from a single cell. Color code is the same as shown in B. (D) Percentage 
of cells activated by increasing concentrations of ATP. The x-axis is log10 of the CCh 
concentration. (E) Ca2+ traces corresponding to the datasets shown in A. Ca2+ signals from all 
153 individual cells are shown. The color assigned to each trace is based on the amplitude of the 
initial response to ATP in each cell at the highest ATP concentration (right-most dataset), i.e. if a 
cell’s trace is colored blue in one set of traces, the same trace in the other data sets is also colored 
blue. 
Figure 5  The initial response to ATP persists in a Ca2+ free bath solution (A) Composite 
Ca2+ images showing the cells that respond to ATP (EC25; red) were reproducible and the 
response persisted when extracellular Ca2+ was removed. Two control responses (A, left panels; 
control and repeat 1) were followed by activation by ATP (EC25) after a 7 minute period in a 
Ca2+ free bath solution. In the Ca2+ free bath, the response to ATP was largely unaltered. In the 
final part of the experiment (repeat 2) Ca2+ was restored to the bathing solution and once again a 
similar response occurred. All images are from the same field of endothelium. (B) Ca2+ signals 
from the activated cells in A, 30s baseline and 60s ATP activation. All traces from individual 
cells are overlaid and the black line is the average. Time of activation is shown above the trace. 
(C) Peak Ca2+ (F/F0) response from each individual cells (circle) matched for each treatment 
(grey line) from a single experiment. Average response indicated by white circle and matched 
across each treatment by bold line. The Plotting Density (right axis) indicates the distribution of 
Peak F/F0 values. (D) Late (steady-state) (F/F0) response measured at 45 s in controls, after 
removal of external Ca2+ and after the return of extracellular Ca2+. (E) Average peak and steady 
state responses to ATP (EC25)  in control (red) and after removal of external Ca2+ (blue); (n=5, 
p>0.05). (F) Composite Ca2+ images showing the cells that respond ATP (EC75; red) 
concentration which also was reproducible and the initial response persisted when extracellular 
Ca2+ was removed. Two control responses (A, left panels; control and repeat 1) were followed by 
activation by ATP (EC75) after a 7 minute period in a Ca2+ free bath solution. In the Ca2+ free 
bath, the response to ATP was largely unaltered. In the final part of the experiment Ca2+ was 
restored to the bathing solution and once again a similar response occurred. All images are from 
the same field of endothelium. (G) Ca2+ signals from the activated cells in F, 30s baseline and 
60s ATP activation. All traces from individual cells are overlaid and the black line is the average. 
Time of activation is shown above the trace. (H) Peak Ca2+ (F/F0) response from each individual 
cells (circle) matched for each treatment (grey line) from a single experiment. Average response 
indicated by white circle and matched across each treatment by bold line. The Plotting Density 
(right axis) indicates the distribution of Peak F/F0 values. (I) Late (steady-state) (F/F0) response 
measured at 45 s in controls, after removal of external Ca2+ and after the return of extracellular 
Ca2+. (J) Average peak and steady state responses to ATP (EC25)  in control (red) and after 
removal of external Ca2+ (blue); (n=5, p>0.05 for the peak response; p<0.05 for the late 
response). All scale bars = 50 µm. 
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Figure 6  ATP activates P2Y2 receptors in the endothelium (A) Representative experiment 
showing the effect of the P2Y1 antagonist MRS2179 (10 µM) and P2Y2 antagonist ARC118925 
(1 µM) on the maximal response to ATP (100 µM). The traces show the average responses from 
all cells in the field. The P2Y1 antagonists (MRS2179, 10 µM) had only a small effect on the 
response. The responses are almost fully blocked by the P2Y2 receptor blocker (ARC118925; 1 
µM). The small residual response is inhibited by the P2Y1 antagonist. At the end of the 
experiment CCh (100 µM) was applied to confirm cell viability. (B) Composite Ca2+ images 
showing the cells that respond to ATP (100 µM) in presence of MRS2179 or ARC118925 (red) 
or both. The right panel shows the cells that response to CCh (100 µM; green) at the end of the 
experiment. All images are from the same field of endothelium. (C) Ca2+ signals from the 
activated cells in B, 30s baseline and 60s activation are shown. (D) Peak Ca2+ (F/F0) response 
from each individual cell (circle) matched for each treatment (grey line) from a single 
experiment. Average response indicated by white circle and matched across each treatment by 
bold line. The Plotting Density (right-hand axis) indicates the distribution of Peak F/F0 values 
(red high, blue low occurrence of the same values). (E) Paired summary data illustrating changes 
in Peak F/F0 response values averaged across all cells. Each color represents a different animal 
and is maintained across the different treatments (n=5). All Scale bars = 50µm. p < 0.05 
Figure 7  Agonists activate spatially-distinct clusters of cells.   (A) Representative composite 
images of Ca2+ activity in the endothelium in response to the EC25 and EC75 concentrations of 
CCh and ATP in a single artery. The first responding (initial 4s; Ai) and total number of cells 
(Aii) activated by the EC25 and EC75 of CCh and ATP are shown. Images are scaled to show all 
activated cells.  (B) The number of activated cells and their spatial relationships were 
calculated from Voronoi neighor analysis and presented as ‘Star maps’. The plot shows the 
cells in the first 4s of activation (dots and lines) by CCh and ATP from the total population of 
cells (grey crosses and cell outlines). The star map shows the same data presented in A (first 
responding). (C,D) plots the number of neighboring cells activated by the EC25 and EC75 of ATP 
and CCh in the first 4 s (C) and total cells activated over the entire data set (D). The total number 
of neighbors was determined for each cell from the Voronoi neighbor analysis (6; black circles) 
and number of these activated for each of the conditions (red circles) is significantly greater 
(p<0.05) from that predicted from a random model of activated cells (blue circles). The 
expectation of the number of neighbors activated randomly was determined as the (mean number 
of neighbours) * (activating fraction) for each agonist. (E) Number of cells activated at the 
concentration shown on the x-axis as a percentage of the total population of cells in the field (red 
and left). “First responding cells” are the cells activated within the first 4s. The right side of each 
plot (E; blue) shows the percentage of precisely the same cells that are activated by each of the 
conditions shown.  The plot shows that those cells that are most sensitive to one agonist are 
much less sensitive to the other.  (F) The number of clusters and number of cells in a cluster 
increase at the EC75 when compared to the EC25 of CCh and ATP. All Scale bars = 50µm. 
Figure 8  Heterogenous distribution of muscarinic and purinergic receptors. (A) 
Fluorescence localization of purinergic P2Y2 receptors and muscarinic M3 receptors in the 
endothelium. Representative images (from left) show the endothelial cell boundaries as revealed 
by PECAM-1 labelling (green; anti- CD31/PECAM-1), P2Y2 receptor (red; anti-P2Y2) 
distribution, M3 receptor distribution (green; fluorescent M3 receptor antagonist, 100 nM) and 
overlay of all three. The receptors distribution was not uniform across the endothelium and there 
was relatively little overlap of purinergic and muscarinic receptor staining. (B) Expanded view of 
the endothelial images shown in A.  The expanded region is shown by the red box in A left-
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panel.  (C) Negative control. The left panel is again PECAM-1 labeled to show cell boundary 
positions.  The negative control for P2Y2 staining was obtained by omitting the primary 
antibody against P2Y2. The control for M3 staining was obtained by labelling with the 
fluorescent M3 receptor ligand in the presence of the M3 receptor antagonist 4-DAMP (10 µM).  
The right panel shows an overlay of all three. (D) Summary data showing the levels of M3 
staining in the presence and absence of the antagonist 4-DAMP (green), the extent of labelling in 
the presence and absence of the P2Y2 primary antibody (red); and the extent of overlap of 
specific M3 and P2Y2 staining (grey). (E) Summary data showing the percentage of cells with 
M3 staining (green), P2Y2 receptor staining (red) and the percentage of cells expressing both M3 
and P2Y2 receptor staining (grey) (n = 3, *p < 0.05, unpaired t-test). All scale bars = 50 μm. 
Figure 9 Signal integration and parallel processing. (A) Composite Ca2+ images showing cells 
that respond in the first 4 seconds of activation by the EC25 concentrations of CCh (left, green) 
and ATP (middle, red).  Images are of the same field of endothelium. The right-panel shows cells 
activated (cyan) in the same field of endothelium when both drugs were applied together.  (B)  
Ca2+ responses from all activate cells in the field of endothelium shown in A.  The Ca2+ increase 
evoked by CCh was on average a slow increase that remained elevated with oscillations (left 
green).  The response to ATP on average was a sharp transient increase that declined towards 
resting values (red middle). When both agonist were applied (combined; blue right) the Ca2+ 
increase appeared to have features of each agonist i.e. a slow but larger initial increase than with 
CCh, which remained more elevated than ATP and slowly declined. Agonists were present for 
the duration indicated by the line above each trace. (C) Examples of responses from 3 separate 
cells to CCh, ATP and to the two agonists when applied together. In each panel in C, traces are 
from the cells indicated by the white dots in the panels in A. It is the same 3 cells in each case. 
Cell 1 is shown in the left panel in C, cell 2 in the middle panel and cell 3 in the right panel.  Cell 
1 (left panel) responds to CCh but not to ATP. The characteristics of the response in Cell 1 is 
altered when both ATP and CCh are present (combined) with a faster and larger upstroke. Cell 2 
responds to ATP but not CCh. Once again the characteristics of the response in Cell 2 is altered 
when both ATP and CCh are present (combined) with a more sustained later Ca2+ change. Cell 3 
responds to each agonist (CCh and to ATP). Once again the characteristics of the response in 
Cell 3 is altered when both ATP and CCh are present (combined).  (D) Mean peak responses 
(black circles) to the EC25 of CCh and ATP separately and when both were present together 
(combined). The red line shows the calculated mean of peak response when both agonists were 
added separately. The red shaded region shows the standard error of the mean. The blue line 
shows the sum of the peak responses when both agonists were added separately. The blue shaded 
region shows the standard error of the mean. The combined peak response exceeded the mean 
and was less than the summed response.  (D) Mean steady-state responses (black circles) to the 
EC25 of CCh and ATP separately and when both were present together (combined). The red line 
shows the calculated mean of the steady-state response when both agonists were added 
separately. The red shaded region shows the standard error of the mean. The blue line shows the 
sum of the steady-state responses when both agonists were added separately. The blue shaded 
region shows the standard error of the mean. The combined steady-state response exceeded both 
the mean and the summed response. All Scale bars = 50µm. 
Figure 10  Signals integration and communication across cells (A) Composite Ca2+ images 
showing cells that respond in the first 4 seconds of activation to the EC25 and EC75 concentrations 
of CCh (green) and ATP (red) and the response to the EC25 concentrations of CCh and ATP 
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when added together (combined; cyan).  All images are from the same field of endothelium. (B) 
Ca2+ responses from the activated cells in A show 30s of baseline and 60s of activation.  (C,D) A 
zoomed region (red box in A) of an example cell (yellow line) that is largely unresponsive to a 
low (EC25; D light green) or a high concentration of CCh (EC75; D, dark green). The same cell 
responded to ATP EC25 (D, light red) and ATP EC75 (D, dark red). The cell’s response to ATP 
EC25 was substantially increased when the EC25 of CCh was also present (right panel, cyan) and 
remained elevated when compared to ATP (EC25) in the absence of CCh. All Scale bars = 50µm. 
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Figure 1 - CCh evoked Ca2+ signals in the endothelium of intact arteries. (A) Ai 
Representative image frame showing ~200 endothelial cells from an imaging field. (Aii) An 
image of cells with automatically identified regions of interest (ROI) superimposed onto the 
imaging field of view. (Aiii) Ca2+ images illustrating the endothelial response during treatment 
with CCh (100nM) overlaid on a basal Ca2+ image. (B) Expanded view of the endothelium 
from the area highlighted in the red box in (A). (C) Baseline-corrected Ca2+ signals (F/F0) 
obtained from the fluorescence within the ROI shown in (B). The color for each trace matches 
that presented in the ROI in B. The fluorescence amplitudes are scaled in the same way for 
each cell. (D) Overlaid Ca2+ signals from all individual cells identified in Aii. The black line 
shows the mean response (E) An example single endothelial cell Ca2+ signal and the 
corresponding images shown in F with time-points indicated by the roman numerals (E,F). 
Scale bars = 50µm. 
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Figure 2  Concentration-dependence of CCh-evoked endothelial Ca2+ signaling. (A) Representative 
composite images of endothelial Ca2+ activity in response to increasing concentrations of CCh. The three 
images show illustrative data from a single artery in which the endothelium was stimulated with 
consecutively increasing concentrations of CCh. The full series applied in each experiment was 10 
increments from 1 nM to 30 µM. Scale bars = 50µm. (B) Average Ca2+ (F/F0) responses from all cells for 
each concentration of the full series. The individual traces are color-coded based on the concentration of 
CCh applied. (C) Ca2+ traces from a single cell. The color code is the same as shown in B. (D) Percentage 
of cells activated by increasing concentrations of CCh. The x-axis is log10 of the CCh concentration. (E) 
Ca2+ traces from all 129 individual cells from the datasets shown in A. The black line is the mean 
response. The other colors assigned to each trace is based on the amplitude of the initial response to CCh 
in each cell at the highest CCh concentration (right-most dataset), i.e. if a cell’s trace is colored blue in 
one set of traces, the same trace in the other two data sets is also colored blue. The color of each specific 
cell’s trace is maintained throughout subsequent additions of agonist allowing for a direct comparison of 
the same cells between responses.  
  
45 
 
Figure 3 CCh activates M3 receptors in the endothelium (A) Representative experiment (average of 
all cells) showing the effect of the selective M3 antagonist 4-DAMP (100 nM). The endothelium was 
activated by CCh at a concentration (100 µM) evoking a maximum response. Two control responses 
show approximately reproducible responses. CCh application is indicated by the line above the traces. 4-
DAMP inhibits the response. After block of M3 receptors, the cells remain viable and respond to ATP 
(100 µM; right-hand trace). (B) Composite Ca2+ images showing the cells that respond to CCh (100 µM; 
green) and an absence of response after the block of M3 receptors by 4-DAMP (100 nM). The subsequent 
application of ATP (100 µM) evoked a response (red). All images are from the same field of endothelium. 
(C) Ca2+ signals from all activated cells in B, 30s baseline and 60s activation. Responses are overlaid and 
the black line is the average. (D) Paired peak Ca2+ (F/F0) responses from each individual cells (circles) 
matched for each treatment (grey line) from a single experiment. Average response indicated by white 
circle and matched across each treatment by bold line. The Plotting Density (right axis) indicates the 
distribution of Peak F/F0 values (red high, blue low occurrence of the same value). (E) Paired summary 
data illustrating changes in Peak F/F0 response values averaged across all cells (n=5). All Scale bars = 
50µm. p < 0.05. 
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Figure 4 Concentration-dependence of ATP-evoked endothelial Ca2+ signaling. (A) Representative 
composite images of Ca2+ activity in carotid artery endothelium in response to stimulation with increasing 
concentrations of ATP. The three images show illustrative data from a single experiment in which the 
endothelium was stimulated with consecutively  increasing concentration of ATP (from 100 nM to 10 
mM). Scale bars = 50µm. (B) Average Ca2+ (F/F0) responses from all cells in (A). The data shows 
responses to each concentration of the full series shown in A. The individual traces are color-coded based 
on the concentration of ATP applied (inset). (C) Ca2+ traces from a single cell. Color code is the same as 
shown in B. (D) Percentage of cells activated by increasing concentrations of ATP. The x-axis is log10 of 
the CCh concentration. (E) Ca2+ traces corresponding to the datasets shown in A. Ca2+ signals from all 
153 individual cells are shown. The color assigned to each trace is based on the amplitude of the initial 
response to ATP in each cell at the highest ATP concentration (right-most dataset), i.e. if a cell’s trace is 
colored blue in one set of traces, the same trace in the other data sets is also colored blue.  
.  
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Figure 5  The initial response to ATP persists in a Ca2+ free bath solution (A) Composite Ca2+ images 
showing the cells that respond to ATP (EC25; red) were reproducible and the response persisted when 
extracellular Ca2+ was removed. Two control responses (A, left panels; control and repeat 1) were 
followed by activation by ATP (EC25) after a 7 minute period in a Ca2+ free bath solution. In the Ca2+ 
free bath, the response to ATP was largely unaltered. In the final part of the experiment (repeat 2) Ca2+ 
was restored to the bathing solution and once again a similar response occurred. All images are from the 
same field of endothelium. (B) Ca2+ signals from the activated cells in A, 30s baseline and 60s ATP 
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activation. All traces from individual cells are overlaid and the black line is the average. Time of 
activation is shown above the trace. (C) Peak Ca2+ (F/F0) response from each individual cells (circle) 
matched for each treatment (grey line) from a single experiment. Average response indicated by white 
circle and matched across each treatment by bold line. The Plotting Density (right axis) indicates the 
distribution of Peak F/F0 values. (D) Late (steady-state) (F/F0) response measured at 45 s in controls, after 
removal of external Ca2+ and after the return of extracellular Ca2+. (E) Average peak and steady state 
responses to ATP (EC25)  in control (red) and after removal of external Ca2+ (blue); (n=5, p>0.05). (F) 
Composite Ca2+ images showing the cells that respond ATP (EC75; red) concentration which also was 
reproducible and the initial response persisted when extracellular Ca2+ was removed. Two control 
responses (A, left panels; control and repeat 1) were followed by activation by ATP (EC75) after a 7 
minute period in a Ca2+ free bath solution. In the Ca2+ free bath, the response to ATP was largely 
unaltered. In the final part of the experiment Ca2+ was restored to the bathing solution and once again a 
similar response occurred. All images are from the same field of endothelium. (G) Ca2+ signals from the 
activated cells in F, 30s baseline and 60s ATP activation. All traces from individual cells are overlaid and 
the black line is the average. Time of activation is shown above the trace. (H) Peak Ca2+ (F/F0) response 
from each individual cells (circle) matched for each treatment (grey line) from a single experiment. 
Average response indicated by white circle and matched across each treatment by bold line. The Plotting 
Density (right axis) indicates the distribution of Peak F/F0 values. (I) Late (steady-state) (F/F0) response 
measured at 45 s in controls, after removal of external Ca2+ and after the return of extracellular Ca2+. (J) 
Average peak and steady state responses to ATP (EC25)  in control (red) and after removal of external 
Ca2+ (blue); (n=5, p>0.05 for the peak response; p<0.05 for the late response). All scale bars = 50 µm 
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Figure 6  ATP activates P2Y2 receptors in the endothelium (A) Representative experiment showing 
the effect of the P2Y1 antagonist MRS2179 (10 µM) and P2Y2 antagonist ARC118925 (1 µM) on the 
maximal response to ATP (100 µM). The traces show the average responses from all cells in the field. 
The P2Y1 antagonists (MRS2179, 10 µM) had only a small effect on the response. The responses are 
almost fully blocked by the P2Y2 receptor blocker (ARC118925; 1 µM). The small residual response is 
inhibited by the P2Y1 antagonist. At the end of the experiment CCh (100 µM) was applied to confirm cell 
viability. (B) Composite Ca2+ images showing the cells that respond to ATP (100 µM) in presence of 
MRS2179 or ARC118925 (red) or both. The right panel shows the cells that response to CCh (100 µM; 
green) at the end of the experiment. All images are from the same field of endothelium. (C) Ca2+ signals 
from the activated cells in B, 30s baseline and 60s activation are shown. (D) Peak Ca2+ (F/F0) response 
from each individual cell (circle) matched for each treatment (grey line) from a single experiment. 
Average response indicated by white circle and matched across each treatment by bold line. The Plotting 
Density (right-hand axis) indicates the distribution of Peak F/F0 values (red high, blue low occurrence of 
the same values). (E) Paired summary data illustrating changes in Peak F/F0 response values averaged 
across all cells. Each color represents a different animal and is maintained across the different treatments 
(n=5). All Scale bars = 50µm. p < 0.05. 
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Figure 7  Agonists activate spatially-distinct clusters of cells.   (A) Representative composite images of Ca2+ 
activity in the endothelium in response to the EC25 and EC75 concentrations of CCh and ATP in a single artery. 
The first responding (initial 4s; Ai) and total number of cells (Aii) activated by the EC25 and EC75 of CCh and 
ATP are shown. Images are scaled to show all activated cells.  (B) The number of activated cells and their 
spatial relationships were calculated from Voronoi neighbor analysis and presented as ‘Star maps’. The plot 
shows the cells in the first 4s of activation (dots and lines) by CCh and ATP from the total population of cells 
(grey crosses and cell outlines). The star map shows the same data presented in A (first responding). (C,D) 
plots the number of neighboring cells activated by the EC25 and EC75 of ATP and CCh in the first 4 s (C) and 
total cells activated over the entire data set (D). The total number of neighbors was determined for each cell 
from the Voronoi neighbor analysis (6; black circles) and number of these activated for each of the conditions 
(red circles) is significantly greater (p<0.05) from that predicted from a random model of activated cells (blue 
circles). The expectation of the number of neighbors activated randomly was determined as the (mean number 
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of neighbors) * (activating fraction) for each agonist. (E) Number of cells activated at the concentration shown 
on the x-axis as a percentage of the total population of cells in the field (red and left). “First responding cells” 
are the cells activated within the first 4s. The right side of each plot (E; blue) shows the percentage of precisely 
the same cells that are activated by each of the conditions shown.  The plot shows that those cells that are most 
sensitive to one agonist are much less sensitive to the other.  (F) The number of clusters and number of cells in 
a cluster increase at the EC75 when compared to the EC25 of CCh and ATP. All Scale bars = 50µm. 
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Figure 8  Heterogenous distribution of muscarinic and purinergic receptors. (A) Fluorescence 
localization of purinergic P2Y2 receptors and muscarinic M3 receptors in the endothelium. 
Representative images (from left) show the endothelial cell boundaries as revealed by PECAM-1 
labelling (green; anti- CD31/PECAM-1), P2Y2 receptor (red; anti-P2Y2) distribution, M3 receptor 
distribution (green; fluorescent M3 receptor antagonist, 100 nM) and overlay of all three. The receptors 
distribution was not uniform across the endothelium and there was relatively little overlap of purinergic 
and muscarinic receptor staining. (B) Expanded view of the endothelial images shown in A.  The 
expanded region is shown by the red box in A left-panel.  (C) Negative control. The left panel is again 
PECAM-1 labeled to show cell boundary positions.  The negative control for P2Y2 staining was obtained 
by omitting the primary antibody against P2Y2. The control for M3 staining was obtained by labelling 
with the fluorescent M3 receptor ligand in the presence of the M3 receptor antagonist 4-DAMP (10 µM).  
The right panel shows an overlay of all three. (D) Summary data showing the levels of M3 staining in the 
presence and absence of the antagonist 4-DAMP (green), the extent of labelling in the presence and 
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absence of the P2Y2 primary antibody (red); and the extent of overlap of specific M3 and P2Y2 staining 
(grey). (E) Summary data showing the percentage of cells with M3 staining (green), P2Y2 receptor 
staining (red) and the percentage of cells expressing both M3 and P2Y2 receptor staining (grey) (n = 3, *p 
< 0.05, unpaired t-test). All scale bars = 50 μm. 
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Figure 9 Signal integration and parallel processing. (A) Composite Ca2+ images showing cells that respond 
in the first 4 seconds of activation by the EC25 concentrations of CCh (left, green) and ATP (middle, red).  
Images are of the same field of endothelium. The right-panel shows cells activated (cyan) in the same field of 
endothelium when both drugs were applied together.  (B)  Ca2+ responses from all activate cells in the field of 
endothelium shown in A.  The Ca2+ increase evoked by CCh was on average a slow increase that remained 
elevated with oscillations (left green).  The response to ATP on average was a sharp transient increase that 
declined towards resting values (red middle). When both agonist were applied (combined; blue right) the Ca2+ 
increase appeared to have features of each agonist i.e. a slow but larger initial increase than with CCh, which 
remained more elevated than ATP and slowly declined. Agonists were present for the duration indicated by the 
line above each trace. (C) Examples of responses from 3 separate cells to CCh, ATP and to the two agonists 
when applied together. In each panel in C, traces are from the cells indicated by the white dots in the panels in 
A. It is the same 3 cells in each case. Cell 1 is shown in the left panel in C, cell 2 in the middle panel and cell 3 
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in the right panel.  Cell 1 (left panel) responds to CCh but not to ATP. The characteristics of the response in 
Cell 1 is altered when both ATP and CCh are present (combined) with a faster and larger upstroke. Cell 2 
responds to ATP but not CCh. Once again the characteristics of the response in Cell 2 is altered when both 
ATP and CCh are present (combined) with a more sustained later Ca2+ change. Cell 3 responds to each agonist 
(CCh and to ATP). Once again the characteristics of the response in Cell 3 is altered when both ATP and CCh 
are present (combined).  (D) Mean peak responses (black circles) to the EC25 of CCh and ATP separately and 
when both were present together (combined). The red line shows the calculated mean of peak response when 
both agonists were added separately. The red shaded region shows the standard error of the mean. The blue 
line shows the sum of the peak responses when both agonists were added separately. The blue shaded region 
shows the standard error of the mean. The combined peak response exceeded the mean and was less than the 
summed response.  (D) Mean steady-state responses (black circles) to the EC25 of CCh and ATP separately and 
when both were present together (combined). The red line shows the calculated mean of the steady-state 
response when both agonists were added separately. The red shaded region shows the standard error of the 
mean. The blue line shows the sum of the steady-state responses when both agonists were added separately. 
The blue shaded region shows the standard error of the mean. The combined steady-state response exceeded 
both the mean and the summed response. All Scale bars = 50µm. 
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Figure 10  Signals integration and communication across cells (A) Composite Ca2+ images showing 
cells that respond in the first 4 seconds of activation to the EC25 and EC75 concentrations of CCh (green) 
and ATP (red) and the response to the EC25 concentrations of CCh and ATP when added together 
(combined; cyan).  All images are from the same field of endothelium. (B) Ca2+ responses from the 
activated cells in A show 30s of baseline and 60s of activation.  (C,D) A zoomed region (red box in A) of 
an example cell (yellow line) that is largely unresponsive to a low (EC25; D light green) or a high 
concentration of CCh (EC75; D, dark green). The same cell responded to ATP EC25 (D, light red) and ATP 
EC75 (D, dark red). The cell’s response to ATP EC25 was substantially increased when the EC25 of CCh 
was also present (right panel, cyan) and remained elevated when compared to ATP (EC25) in the absence 
of CCh. All Scale bars = 50µm. 
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SUPPLEMENTARY DATA 
 
   
Supplementary Figure S1  CCh evoked Ca2+ signals in the endothelium. (A) F/F0 Ca2+ 
signals for each of the individual cells shown in B, each line is a different cell. (B) Composite 
Ca2+ images illustrating the endothelial response at specific timepoints (Bi-iii) during treatment 
with CCh (10 µM). (Biv) Image showing all responding cells to CCh over the entire recording. 
(C) F/F0 Ca2+ signals of single cells (from B), overlaid and baseline normalized. (D) Baseline-
corrected and time-aligned Ca2+ signals (from C), shown over an expanded time-scale (grey 
region in C). The Ca2+ signals have been colored according to the amplitude of the first rise in 
Ca2+. Red indicates the highest amplitude and blue, the lowest amplitude. (E) Automatically 
generated regions of interest (ROIs; red) for each cell shown overlaid on a sharpened basal 
Ca2+ image. The blue square surrounding the entire field shows the whole-field ROI used for 
average analysis shown in F. (F) Baseline-corrected Ca2+ signals (F/F0) obtained by 
averaging fluorescence within the whole field ROI (blue) and by average each cellular Ca2+ 
signal (red). (G) Schematic indicating the timing of agonist addition, wash and recovery used 
in the experiments. During each agonist addition there was a 2 min recording of baseline 
followed by 3 min of activation. Scale bars = 50µm
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Supplementary Figure S2  Flow-induced endothelial Ca2+ signalling (A) Representative composite images of Ca2+ 
activity in carotid artery endothelium in response to stimulation with flow (1.5 ml/min) and ACh (300 nM). The three 
images show the same field of endothelium from a single experiment. The endothelium was stimulated with flow (A, 
left panel), flow before the addition of ACh (A, middle panel) and ACh in the presence of a flow-induced response (A, 
right panel). Scale bars = 50 µm. (B) Ca2+ traces corresponding to the datasets shown in A. Ca2+ signals are from all 
154 activated individual cells are shown. The color assigned to each trace is based on the amplitude of the initial 
response to flow in each cell i.e. if a cell’s trace is colored red in one set of traces, the same trace in the other data sets 
is also colored red. (C) Average Ca2+ (ΔF/F0) response from each individual cell (circle) matched for each treatment 
(grey line) from a single experiment. The average response is indicated by white circle and matched across each 
treatment by bold line. The Plotting Density (right axis) indicates the distribution of average ΔF/F0 values. (D) 
Summary data of average Ca2+ responses to flow, flow before the addition of ACh and ACh in the presence of flow 
induced Ca2+ signals (n=3). (E) Histogram illustrating the frequency distribution of the number of peaks/cell/minute. 
(F) Summary data of the number of peaks/cell/minute to flow, flow before the addition of ACh and ACh in the 
presence of flow induced Ca2+ signals (n=3). 
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  Supplementary Figure S3  Endothelial Ca2+-dependence of CCh- and ATP-evoked relaxation (A) 
Representative experiment showing the vasorelaxant effects of ATP (100 µM) and CCh (100 µM) on arteries 
constricted by 20% from their maximal diameter by phenylephrine. Experiments, carried out in the same 
artery, show the effects of selective buffering of endothelial Ca2+ using the cell-permeable selective Ca2+-
chelator, BAPTA-AM (30 µM). (B) Brightfield image showing a pressurized carotid artery (110 mmHg) 
contracted to phenylephrine (left-panel). The middle and right-panels show the same artery under the effects 
of CCh and ATP as indicated, both in the absence (top row) and presence (bottom row) of BAPTA-AM. The 
red line indicates the diameter of the artery in the absence of BAPTA-AM at each of the conditions indicated. 
(C) Summary data showing the vasorelaxant effects of the muscarinic receptor agonist CCh and purinergic 
receptor agonist ATP on a preconstricted pressurised artery (n = 3, *p < 0.05). All scale bars = 200 µm. 
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Supplementary Figure S4 Concentration-dependence of the CCh-evoked 
endothelial Ca2+ response. (A-D) Summary data illustrating the concentration 
dependence of the endothelial response to CCh (n = 5): (A) magnitude of the initial 
peak (ΔF/F0) in the Ca2+ response to CCh, this data presents average values of cells 
that responded to each concentration. (B) Concentration dependence of total 
endothelial activity, this data is the overall response averaged across the endothelium, 
the response of those cells that do not respond is considered zero. The averages of 
each concentration response were normalized to the maximal response within the 
experiment; (C) Representative concentration response obtained from three 
individual cells within a single experiment series. (D) Histograms showing latency 
distributions. Fitted curves were obtained by Gaussian kernel density estimation. 
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Supplementary Figure S5  Concentration-dependence of the ATP-evoked 
endothelial Ca2+ response. (A-D) Summary data illustrating the concentration 
dependence of the endothelial response to ATP (n = 5): (A) magnitude of the initial 
peak (ΔF/F0) in the Ca2+ response to ATP, this data presents average values of cells 
that responded at each concentration (B) Concentration dependence of total 
endothelial activity, this data represent the overall response averaged across the 
endothelium, the response of those cells that do not respond is considered zero. The 
averages of each concentration response were normalized to maximal response 
within each experiment; (C) Representative concentration response obtained from 
three individual cells within a single experiment series. (D) Histograms showing 
latency distributions. Fitted curves were obtained by Gaussian kernel density 
estimation.
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Supplementary Figure S6  The pattern of cell activation is unaltered by sequence of agonist 
addition (A) Composite Ca2+ images showing cells that respond to the EC25 concentration of 
CCh (green) and ATP (red). In the first part of the experiment, CCh was applied and after wash 
and recovery then ATP (see supplementary Fig 1G for protocol). Next, ATP was applied and 
after wash and recovery then CCh. All images are from the same field of endothelium. (B) Ca2+ 
responses from the activated cells in A. 30s of baseline and 60s of activation are shown. (C) Heat 
map showing a combination of all cells that respond to either CCh or ATP. Each row illustrates 
an individual endothelial cell and the order is maintained across all four treatments. (D-E) Paired 
data from a single experiment showing the peak F/F0 values of only the active cells (circles). The 
Plotting Density (right axis) indicates the distribution of Peak F/F0 values (red high overlap of 
values, blue low overlap of values). All Scale bars = 50µm.   
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Supplementary Figure S7 Specificity of the P2Y2 receptor antibody (A) Fluorescence 
localization of purinergic P2Y2 receptors in human astrocytes (1321N1 cells; which lack all 
eight P2Y subtypes). Representative images (from left) show astrocyte cell nuclei (blue; DAPI), 
P2Y2 receptor distribution (red; anti-P2Y2) and overlay of both (B) Fluorescence localization of 
purinergic P2Y2 receptors in 1321N1-hP2Y2 cells which stably express recombinant human 
hP2Y2 receptors. Representative images (from left) show astrocyte cell nuclei (blue; DAPI), 
P2Y2 receptor distribution (red; anti-P2Y2) and overlay of both (C) Summary data showing the 
level of P2Y2 receptor staining in wild-type (black) and hP2Y2 (grey) cells. (D) Summary data 
showing the number of cells in each field of view. (n = 3, *p < 0.05, unpaired t-test). All scale 
bars = 50 μm. 
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Supplementary Figure S8  Heterogeneity in nitric oxide production (A) Heat map showing 
the cells (left axis) that respond to the EC50 (for Ca2+) of CCh and ATP with nitric oxide 
production as measured by DAR-4M in the same preparation. Each row in the panels illustrates 
an individual endothelial cell and the order is maintained across all treatments.  (A) left-panels, 
shows the cells that respond to CCh alone i.e. nitric oxide production in response to CCh but not 
ATP.  (A) right-panels shows the cells that respond to ATP alone i.e. nitric oxide production in 
response to ATP but not CCh. (B-C) Number of cells activated as a percentage of the total 
population of cells in the field (red bar, left side). The right side of each plot (B-C, blue bars) 
shows the percentage of precisely the same cells that are activated by each of the conditions 
shown on the x axis.  The plots show that those cells that are most sensitive to one agonist in 
producing nitric oxide are much less sensitive to the other agonist (n=3). There is a significant 
difference in the cells that respond to each agonist (p<0.05). 
 
